These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 31128313

  • 1. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.
    Liu P, Xiao Q, Zhou B, Dai Z, Kang Y.
    World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313
    [Abstract] [Full Text] [Related]

  • 2. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV, Tsvetkova V, Griguolo G, Miglietta F, Tasca G, Giorgi CA, Cumerlato E, Massa D, Lo Mele M, Orvieto E, Guarneri V, Conte P.
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [Abstract] [Full Text] [Related]

  • 3. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
    El-Guindy DM, Helal DS, Sabry NM, Abo El-Nasr M.
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer.
    Wang Q, Lou W, Di W, Wu X.
    Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
    [Abstract] [Full Text] [Related]

  • 5. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
    Hu C, Tian S, Lin L, Zhang J, Ding H.
    Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
    Wang H, Li Z, Dong B, Sun W, Yang X, Liu R, Zhou L, Huang X, Jia L, Lin D.
    Diagn Pathol; 2018 May 22; 13(1):30. PubMed ID: 29789013
    [Abstract] [Full Text] [Related]

  • 7. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
    Tomioka N, Azuma M, Ikarashi M, Yamamoto M, Sato M, Watanabe KI, Yamashiro K, Takahashi M.
    Breast Cancer; 2018 Jan 22; 25(1):34-42. PubMed ID: 28488168
    [Abstract] [Full Text] [Related]

  • 8. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX, Lv GH, Wang XB, Huang W, Li J, Jiang Y, She XL.
    Neurosurgery; 2019 Jun 01; 84(6):E318-E333. PubMed ID: 30032257
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
    Diana A, Wang LM, D'Costa Z, Allen P, Azad A, Silva MA, Soonawalla Z, Liu S, McKenna WG, Muschel RJ, Fokas E.
    Oncotarget; 2016 Jul 05; 7(27):40992-41004. PubMed ID: 27329602
    [Abstract] [Full Text] [Related]

  • 10. Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.
    Okabe M, Toh U, Iwakuma N, Saku S, Akashi M, Kimitsuki Y, Seki N, Kawahara A, Ogo E, Itoh K, Akagi Y.
    Cancer Sci; 2017 Jan 05; 108(1):81-90. PubMed ID: 27801993
    [Abstract] [Full Text] [Related]

  • 11. Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC).
    Farrag MS, Abdelwahab K, Farrag NS, Elrefaie WE, Emarah Z.
    J Egypt Natl Canc Inst; 2021 Jul 09; 33(1):16. PubMed ID: 34241710
    [Abstract] [Full Text] [Related]

  • 12. The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene.
    Li Y, Opyrchal M, Yao S, Peng X, Yan L, Jabbour H, Khoury T.
    Breast Cancer Res Treat; 2018 Jul 09; 170(2):293-302. PubMed ID: 29524062
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y, Liang L, Dai W, Cai G, Xu Y, Li X, Li Q, Cai S.
    Mol Cancer; 2016 Aug 24; 15(1):55. PubMed ID: 27552968
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological correlation of PD-L1 and TET1 expression with tumor-infiltrating lymphocytes in non-small cell lung cancer.
    Ahn H, Lee HJ, Lee JH, Cho HD, Oh MH, Son JW, Jang SH.
    Pathol Res Pract; 2020 Nov 24; 216(11):153188. PubMed ID: 32919305
    [Abstract] [Full Text] [Related]

  • 15. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer.
    Kesar N, Winkelmann R, Oppermann J, Ghanaati S, Martin D, Neumayer T, Balster S, Rödel C, Rödel F, von der Grün J, Balermpas P.
    Oral Oncol; 2020 Dec 24; 111():104931. PubMed ID: 32736208
    [Abstract] [Full Text] [Related]

  • 16. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
    Berghoff AS, Ricken G, Wilhelm D, Rajky O, Widhalm G, Dieckmann K, Birner P, Bartsch R, Preusser M.
    J Neurooncol; 2016 Oct 24; 130(1):19-29. PubMed ID: 27436101
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ.
    World J Gastroenterol; 2019 Apr 14; 25(14):1684-1696. PubMed ID: 31011254
    [Abstract] [Full Text] [Related]

  • 18. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
    Lim YJ, Koh J, Kim K, Chie EK, Kim B, Lee KB, Jang JY, Kim SW, Oh DY, Bang YJ, Ha SW.
    Radiother Oncol; 2015 Oct 14; 117(1):165-70. PubMed ID: 26235847
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Significance of Categorizing Gastric Carcinoma by PD-L1 Expression and Tumor Infiltrating Lymphocytes.
    Noh BJ, Kim JH, Eom DW.
    Ann Clin Lab Sci; 2018 Nov 14; 48(6):695-706. PubMed ID: 30610038
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE, Abdelrahman AE, Abdelgawad M, Balata S, Shabrawy ME.
    Turk Patoloji Derg; 2017 Nov 14; 1(1):211-222. PubMed ID: 28832075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.